首页> 外文期刊>Intensive Care Medicine >The Crystalloid versus Hydroxyethyl Starch Trial: protocol for a multi-centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality
【24h】

The Crystalloid versus Hydroxyethyl Starch Trial: protocol for a multi-centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality

机译:《晶体学与羟乙基淀粉试验》:一项针对重症监护患者死亡率的多中心随机对照试验,采用6%羟乙基淀粉(130 / 0.4)和0.9%氯化钠(盐水)进行液体复苏的多中心随机对照试验

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose The intravenous fluid 6% hydroxyethyl starch (130/0.4) (6% HES 130/0.4) is used widely for resuscitation but there is limited information on its efficacy and safety. A large-scale multi-centre randomised controlled trial (CHEST) in critically ill patients is currently underway comparing fluid resuscitation with 6% HES 130/0.4 to 0.9% sodium chloride on 90-day mortality and other clinically relevant outcomes including renal injury. This report describes the study protocol.
机译:目的6%羟乙基淀粉(130 / 0.4)(6%HES 130 / 0.4)静脉注射液被广泛用于复苏,但有关其功效和安全性的信息有限。目前正在进行一项针对重症患者的大型多中心随机对照试验(CHEST),比较了6%的HES 130 / 0.4至0.9%氯化钠的液体复苏对90天死亡率和其他临床相关结果(包括肾损伤)的影响。该报告描述了研究方案。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号